We commend Louise Ivers and colleagues (Dec 18, p 2048) 1 for their thoughts around advocating for complementary public health inter ventions that could slow the cholera epidemic in Haiti. We are also particularly grateful to Partners In Health for the synergistic, helpful, and timely support provided to our medical action during the onset of the outbreak in the Artibonite region.
Ivers and colleagues highlight the enormous potential benefi ts (shorter duration of illness, decreased volume of diarrhoea, and decreased duration of pathogen shedding) associated with the proper use of antibiotics. 1 We concur, but would like to suggest the further need to add the systematic use of zinc for all paediatric patients (those younger than 15 years). Supplementation with zinc in children with cholera has been shown to present an additional benefi t over antimicrobial treatment by reducing the duration of diarrhoea and overall stool output.
2
This eff ect can contribute substantially to decreased severity and a reduced overall burden of the disease. The US Centers for Disease Control and Prevention support the use of zinc for the paediatric population. Moreover, zinc has been proven to be eff ective in enhancing the T-cell and B-cell-driven sero conversion to vibriocidal antibodies in children given the oral inactivated cholera vaccine. 4, 5 This aspect is particularly crucial if we want to improve vaccine eff ectiveness and achieve, in the years to come, a meaningful preventive protection rate, aimed at saving thousands of lives.
We declare that we have no confl icts of interest. 
*Gabriele

Authors' reply
We would like to thank Gabriele Rossi and colleagues for drawing the reader's attention to the role of zinc in cholera treatment. We are also deeply grateful for the essential health services that their organisation, Médecins Sans Frontières, has provided to Haiti since the beginning of the cholera outbreak and for many years preceding. We fully agree with the suggestion by Rossi and colleagues to include zinc supplementation as an integral part of the treatment for cholera patients, especially children. Zinc supple ments have been shown to reduce the severity and duration of diarrhoea, particularly in children younger than 5 years, and are therefore recom mended by WHO for patients with most diarrhoeal diseases, including cholera. In a study in Bangladeshi children with cholera, zinc reduced vomiting, stool output and duration, and hospital stay by 8 h.
1 A review of effi cacy studies on this subject found zinc treatment to decrease diarrhoea-related mortality by 23%.
2
WHO recommends that 10-20 mg of zinc be given every day for 10-14 days to all children with diarrhoea; shortcourse zinc supplementation reduces the incidence of diarrhoea for 2-3 months.
3 One study indicates that 5 days of treatment can be as effi cacious as the 10-day treatment in preventing diarrhoea in the sub sequent 3 months among children in Bangladesh. 4 We are currently part of a col laborative academic eff ort of more than 40 individuals, including physicians, public health profes sionals, and other cholera experts, to synthesise a comprehensive strategy of integrated prevention and care for Haiti and elsewhere. Zinc is discussed in this joint statement as a crucial component of the treatment regimen for cholera. To respond to Haiti's current cholera epidemic, we must continue to scale up aggressive case fi nding and treatment eff orts, including oral rehydration therapy, intravenous rehydration, antibiotic therapy, and complementary supple mentation with zinc and vitamin A. to higher costs of subsequent outpatient health-care encounters. 4 According to the US Centers for Disease Control and Prevention, most of these adverse drug events are caused by generic drugs, 3 for which no incentives exist for the private sector to invest in safety and effi cacy research. By designating translational research on improved safety and effi cacy of generic drugs among its key missions, the large foreseen public investment in the proposed NCATS might be off set by reduced health-care costs associated with adverse drug events and by improved effi cacy. Besides, it will increase public trust in the government's concern for personal health and wellbeing.
We declare that we have no confl icts of interest. Treatment must be linked to prevention, including mass vaccination, expanded water and sanitation eff orts, and public health messaging that is tied to delivery of needed resources (such as soap). All of this must be led by the Haitian Government to mitigate the acute problem of cholera in the short term while also strengthening Haiti's public water, sanitation, and health systems in the long term.
*David Gurwitz, Jeantine E Lunshof
*Paul Farmer, Louise Ivers
Violence against Chinese health-care workers
The Lancet has kept a close watch on the situation of Chinese health-care workers who have been wounded, disabled, or even killed by patients or their relatives (Feb 19, p 639).
1,2
We give some possible causes of this situation. First, under the family control policy, most Chinese families have only one child who becomes the core of the family. Thus parents and grandparents pay great attention to the health of their child. High-income and uppermiddle-income parents particularly demand higher-quality health services for their children.
Second, out-of-pocket health-care payments are high. Starved of funds from the government, Chinese hos pitals resort to prescribing expensive, and often unnecessary, drugs, diagnostics, and procedures. These growing out-ofpocket payments place a heavy burden on poor households. Poor workers and their dependants (children, spouses, and parents) have high expectations of the therapeutic effi cacy of such expensive treatments.
The situation above stems from a common lack of medical understanding among the general public. Many patients, if a disease progresses, will instinctively blame doctors rather than taking a reasonable attitude to the disease. The Chinese mass media have reported many medical disputes in recent years, but they have not taken the opportunity to spread general medical knowledge.
Finally, the low quality of medical services in Chinese hospitals is universal. Some junior doctors receive little regular training, mean ing that their clinical skills are inadequate. Additionally, many health-care work ers are not medically qualifi ed at all, and currently it is still a great challenge for hospitals to verify the qualifi cations of their staff .
We declare that we have no conflicts of interest. China has about 20% of the world's population, yet its national health expenditure is only 2% of the total world expenditure on health.
*Sheng-Li
2 Although China's gross domestic product (GDP) has become one of the world's largest, the total expenditure on health is only 4·3% of GDP, only 44·7% of which is govern ment expenditure.
3 Insuffi cient in vest ment in public health has become a bottleneck in the development of Chinese society. Improving the fi nancial input into public health and rebuilding a harmonious doctorpatient relationship are vital for China's health-system reform.
*
Joined-up thinking in reduction of cardiovascular risk
Your Editorial highlighting an expected epidemic of premature cardiovascular mortality (Feb 12, p 527) 1 makes for interesting and rather frightening reading for any frontline clinician already labouring under this seemingly insurmountable burden.
But surely extraordinary circumstances call for extraordinary
